Alprostadil 5 mcg/ml solution
Dose: 0.05 to 0.10 mcg/kg/min IV |
Frequency: Continuous infusion |
Comments: Alprostadil is a prostaglandin used to
maintain blood flow through the ductus arteriosus when this structure is essential for
maintaining either pulmonary or systemic circulation. The use of prostaglandins have
allowed for stabilization of infants and the prevention of tissue hypoxia and acidosis
which can adversely effect myocardial function and pulmonary vascular resistance.
Surgery can then be carried out under less emergent conditions with improved
survival. Further comments on alprostadil.
The following table lists congenital heart lesions potentially responsive to
alprostadil: 1. Severe tetralogy of Fallot 2. Critical pulmonary stenosis/pulmonary atresia 3. Tricuspid atresia DUCTUS DEPENDENT SYSTEMIC BLOOD FLOW 1. Aortic arch interruption 2. Juxtaductal coarctation of the aorta 3. Hypoplastic left heart syndrome TRICUSPID VALVE ANOMALIES 1. Tricuspid insufficiency 2. Ebstein's anomaly TRANSPOSITION OF THE GREAT ARTERIES 1. Without restricted pulmonary blood flow |
| Toxicity: Approximately 18% of infants may exhibit cardiovascular side effects, the most common of which are cutaneous vasodilatation and edema. Although much less common, arrhythmias and hypotension may also occur. Respiratory depression and apnea can be seen in as many as 12% of infants, especially in those weighing less than 2 kg. This is dose-related and is not typically seen with infusions < 0.05 mcg/kg/min. The relationship between the use of alprostadil and infection remains controversial. Other side effects which may occur include: temperature elevation, seizure-like activity, irritability, muscle twitching or jitteriness, lethargy, hypoglycemia, hypocalcemia, hyperbilirubinemia, diarrhea, and thrombocytopenia. The majority of the above problems are minor compared to the clinical situation of the infant's need for treatment. See adverse reactions associated with alprostadil. |
Preparation: | |
Compatibility: Alprostadil is compatible with TPN
(2% solution), though no information is available about the filter. It is also compatible
with D5W, D10W, D15W, D20W, dobutamine, dopamine, epinephrine, fentanyl, midazolam, and
morphine. The information is based on an upcoming paper "Chemical
and physical stability of alprostadil with total parenteral nutrition, and selected
intravenous medications" by Mark MacKay BS RPh, David Mann BS RPh, William Rusho BS
RPh, MS, John Sweeley BS, and Ralph A. Lugo Pharm D. | |
Weight |
0.05 mcg/kg/min |
0.01 mcg/kg/min |
Weight |
0.05 mcg/kg/min |
0.01 mcg/kg/min |
1000 |
0.60 ml/hr |
0.12 ml/hr |
3250 |
1.95 ml/hr |
0.39 ml/hr |
1250 |
0.75 ml/hr |
0.15 ml/hr |
3500 |
2.10 ml/hr |
0.42 ml/hr |
1500 |
0.90 ml/hr |
0.18 ml/hr |
3750 |
2.25 ml/hr |
0.45 ml/hr |
1750 |
1.05 ml/hr |
0.21 ml/hr |
4000 |
2.40 ml/hr |
0.48 ml/hr |
2000 |
1.20 ml/hr |
0.24 ml/hr |
4250 |
2.55 ml/hr |
0.51 ml/hr |
2250 |
1.35 ml/hr |
0.27 ml/hr |
4500 |
2.70 ml/hr |
0.54 ml/hr |
2500 |
1.50 ml/hr |
0.30 ml/hr |
4750 |
2.85 ml/hr |
0.57 ml/hr |
2750 |
1.65 ml/hr |
0.33 ml/hr |
5000 |
3.00 ml/hr |
0.60 ml/hr |
3000 |
1.80 ml/hr |
0.36 ml/hr |
5250 |
3.15 ml/hr |
0.63 ml/hr |